LRMR — Larimar Therapeutics Share News
0.000.00%
Last trade - 00:00- $313.73m
- $157.46m
Larimar tumbles as safety concerns resurface in rare disease drug study update
U.S. STOCKS ON THE MOVE-Regenxbio, Repay, Natera, Fortune Brands
U.S. STOCKS ON THE MOVE-SpaceX, Charter, Gulfport Energy
Larimar tumbles as safety concerns resurface in rare disease drug study update
U.S. RESEARCH ROUNDUP- Agilent Technologies, Fedex, Synopsys
Larimar Therapeutics Q1 net loss widens slightly R&D expenses fall
Brief: Larimar Therapeutics Q1 Net Income USD -29.613 Million
Larimar Therapeutics Q4 net loss widens on higher R&D costs
U.S. STOCKS ON THE MOVE-Enovis, Cheniere, Packaging Corp of America
U.S. STOCKS ON THE MOVE-Qnity, J.M. Smucker, Vistra
Larimar Therapeutics retreats on hiked $100 mln stock sale
Brief: Larimar Therapeutics Announces Pricing Of Upsized $100 Million Underwritten Public Offering
Larimar Therapeutics slips after $75 mln stock offering commenced
U.S. STOCKS ON THE MOVE-Domino's Pizza, FactSet, IBM
U.S. STOCKS ON THE MOVE-Henry Schein, Domino's Pizza, FactSet
U.S. STOCKS ON THE MOVE-Advanced Micro Devices, Constellation Energy, NRG Energy
Larimar jumps on FDA's 'breakthrough' tag for neurological disorder therapy
Brief: Larimar Therapeutics Announces FDA Breakthrough Therapy Designation For Nomlabofusp
Larimar Therapeutics Q3 net loss widens